本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

InVivo Therapeutics Holdings Corp

0.3207
+0.0000
成交量:- -
成交額:- -
市值:99.59萬
市盈率:-0.09
高:0.3207
開:0.3207
低:0.3207
收:0.3207
資料載入中...
2021/11/16

重要事件披露

8-K - Current report
2021/11/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/16

重要事件披露

8-K - Current report
2021/06/01

重要事件披露

8-K - Current report
2021/05/21

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

重要事件披露

8-K - Current report
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/08

重要事件披露

8-K - Current report
2020/11/06

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]